CacheBy
Thermo Fisher Scientific PAI1 Recombinant Rabbit Monoclonal Antibody (6H2L3)
원본

Thermo Fisher Scientific PAI1 Recombinant Rabbit Monoclonal Antibody (6H2L3)

상품 한눈에 보기

Recombinant rabbit monoclonal antibody targeting human PAI1, validated for WB and ICC/IF applications. Offers high specificity, sensitivity, and lot-to-lot consistency. Supplied as 0.5 mg/mL liquid, unconjugated form, ideal for research use only.

카탈로그번호
701096
판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 07. 03. 오후 07:12
Thermo Fisher Scientific 701096 PAI1 Recombinant Rabbit Monoclonal Antibody (6H2L3) 100 ug pk판매 단위 pk ·
재고 확인 필요
견적요청

Thermo Fisher Scientific · Thermo Fisher Scientific PAI1 Recombinant Rabbit Monoclonal Antibody (6H2L3)

Applications

Application Tested Dilution
Western Blot (WB) 0.1–2 µg/mL
Immunocytochemistry (ICC/IF) 2.5 µg/mL

Product Specifications

Specification Description
Host / Isotype Rabbit / IgG
Class Recombinant Monoclonal
Type Antibody
Clone 6H2L3
Immunogen Recombinant protein corresponding to amino acids 210–354 of human plasminogen activator inhibitor 1
Conjugate Unconjugated
Form Liquid
Concentration 0.5 mg/mL
Storage Conditions Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Shipping Conditions Wet ice
RRID AB_2532385

Product Specific Information

Intact IgG appears on a non-reducing gel as a ~150 kDa band and upon reduction generates a ~25 kDa light chain and a ~50 kDa heavy chain.
Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems developed by cloning specific antibody DNA sequences from immunoreactive rabbits. Individual clones are screened to select optimal candidates for production.

Advantages of recombinant rabbit monoclonal antibodies:

  • High specificity and sensitivity
  • Excellent lot-to-lot consistency
  • Animal origin-free formulations
  • Broader immunoreactivity due to large rabbit immune repertoire

Target Information

PAI1 (plasminogen activator inhibitor 1) belongs to the serine protease inhibitor superfamily and is the principal inhibitor of tissue-type and urokinase-type plasminogen activators (tPA and uPA).
Platelets are the main source of circulating PAI1, but it is also synthesized by fibroblasts, smooth muscle cells, endothelial cells, hepatocytes, and inflammatory cells.

Expression of PAI1 is regulated by multiple factors including growth factors, cytokines, hormones, inflammatory stimuli, metabolites, and environmental conditions. Elevated PAI1 levels are associated with disease states such as obesity, thrombophilia, and metabolic syndrome. Defects in PAI1 can lead to abnormal bleeding and fibrinolysis inhibition.

Alternatively spliced transcript variants encoding different isoforms of PAI1 have been identified.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.